ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

32,534Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 780

$1.94M Total Retail Price of All Prescriptions

Rank: 7 out of 780

1,016 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 1,016 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 1,016 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 23,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,524 879 S3 1 1
LEVOTHYROXINE SODIUM 1,397 1,133 2 5
OMEPRAZOLE 1,177 691 3 3
SIMVASTATIN 1,078 786 4 2
METFORMIN HCL 814 653 5 8
LISINOPRIL 741 562 6 6
CARVEDILOL 710 523 7 14
AMLODIPINE BESYLATE 674 478 8 4
PRAVASTATIN SODIUM 623 467 9 9
GABAPENTIN 541 309 10 13
ATORVASTATIN CALCIUM 416 299 11 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 400 263 12 26
METOPROLOL TARTRATE 390 323 13 19
MELOXICAM 382 278 14 16
NEXIUM 365 262 15 22
FENOFIBRATE 355 204 16 63
ALENDRONATE SODIUM 353 308 17 44
CRESTOR 346 291 18 32
HYDROCHLOROTHIAZIDE 342 294 19 10
FUROSEMIDE 322 206 20 7
ATENOLOL 300 173 21 21
RAMIPRIL 298 228 22 70
WARFARIN SODIUM 293 270 23 24
ZOLPIDEM TARTRATE 275 155 24 17
CLOPIDOGREL 272 227 25 34
CITALOPRAM HBR 269 145 26 23
GLIMEPIRIDE 267 198 27 30
LOSARTAN POTASSIUM 246 133 28 18
COMBIVENT 242 168 29 189
CIPROFLOXACIN HCL 241 172 30 49
ROPINIROLE HCL 239 162 31 87
AMITRIPTYLINE HCL 232 162 R 32 48
AMLODIPINE BESYLATE-BENAZEPRIL 229 185 33 50
ZEMPLAR 222 211 34 293
METOPROLOL SUCCINATE 221 185 35 20
LOSARTAN-HYDROCHLOROTHIAZIDE 215 205 36 33
LYRICA 207 112 37 52
LOVASTATIN 206 191 38 47
SERTRALINE HCL 200 112 39 27
POTASSIUM CHLORIDE 192 153 40 11
TRICOR 178 140 41 152
GEMFIBROZIL 177 148 42 104
LEVOFLOXACIN 174 129 43 76
PREDNISONE 173 146 44 40
CLONIDINE HCL 172 103 45 28
CALCITRIOL 163 134 46 274
CYMBALTA 162 123 47 51
PLAVIX 162 141 47 45
DONEPEZIL HCL 160 155 49 31
POLYETHYLENE GLYCOL 3350 158 89 50 79
JANUVIA 158 155 50 85
DIOVAN HCT 157 148 52 75
SYMBICORT 154 126 53 181
TRIAMTERENE-HCTZ 154 129 53 37
SPIRIVA 153 137 55 72
CARISOPRODOL 152 41 R 56 67
MORPHINE SULFATE ER 151 79 S2 57 141
TRAZODONE HCL 146 86 58 35
AZITHROMYCIN 146 84 58 38
TAMSULOSIN HCL 145 112 60 36
ISOSORBIDE MONONITRATE ER 145 103 60 60
PAROXETINE HCL 143 87 62 69
TIZANIDINE HCL 136 58 63 82
GLYBURIDE 136 124 R 63 101
SINGULAIR 135 70 65 73
SYNTHROID 134 129 66 77
VENLAFAXINE HCL ER 130 106 67 117
PANTOPRAZOLE SODIUM 130 117 67 25
DOXEPIN HCL 129 90 69 170
CARBIDOPA-LEVODOPA 129 93 69 124
INSULIN SYRINGE 128 79 71 80
ADVAIR DISKUS 127 97 72 68
BENAZEPRIL HCL 126 111 73 59
ALLOPURINOL 124 88 74 29
RANITIDINE HCL 122 75 75 39
QUINAPRIL HCL 117 89 76 113
ESCITALOPRAM OXALATE 115 85 77 61
FLUOXETINE HCL 114 67 78 65
CYCLOBENZAPRINE HCL 113 27 R 79 42
HUMULIN 70-30 112 36 80 106
AVODART 112 109 80 255
FLUTICASONE PROPIONATE 107 72 82 41
TRAMADOL HCL-ACETAMINOPHEN 106 81 83 140
TOPIRAMATE 106 11 83 145
ENDOCET 105 40 S2 85 129
METHOCARBAMOL 105 38 R 85 84
TRAMADOL HCL 103 70 87 15
LANTUS SOLOSTAR 102 76 88 121
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 44 89 88
PEN NEEDLE 98 51 90 136
ENALAPRIL MALEATE 98 70 90 64
SUCRALFATE 95 66 92 149
ACTONEL 93 93 93 264
ZETIA 92 78 94 94
DILTIAZEM ER 91 68 95 134
NIASPAN 91 71 95 167
NAPROXEN 90 67 97 100
DIGOXIN 88 69 98 56
LOVAZA 88 64 98 183
FENTANYL 87 0 S2 100 107
DIOVAN 87 59 100 55
VESICARE 82 58 102 186
MONTELUKAST SODIUM 81 32 103 120
FOSINOPRIL SODIUM 80 60 104 112
NIFEDIPINE ER 80 78 104 115
IBUPROFEN 79 55 106 93
EVISTA 78 78 107 151
NAMENDA 78 78 107 46
NIFEDICAL XL 76 61 109 209
SOTALOL 75 75 110 312
ADVAIR HFA 74 50 111 360
GLYBURIDE-METFORMIN HCL 73 73 R 112 108
PROMETHAZINE HCL 71 23 R 113 66
BACLOFEN 71 40 113 153
LIPITOR 71 58 113 175
LEVOXYL 70 56 116 279
GLIPIZIDE ER 66 35 117 109
ACTOS 65 55 118 144
SPIRONOLACTONE 65 49 118 53
PREMARIN 62 49 R 120 110
VENTOLIN HFA 62 42 120 91
NOVOLOG MIX 70-30 FLEXPEN 61 24 122 222
DOXAZOSIN MESYLATE 60 60 123 97
TORSEMIDE 60 60 123 114
LAMOTRIGINE 60 21 123 205
ONGLYZA 59 37 126 232
CALCIUM ACETATE 59 41 126 344
LANTUS 59 45 126 71
AMOXICILLIN 58 29 129 99
VERAPAMIL ER 57 55 130 78
LEVEMIR FLEXPEN 57 38 130 211
BUPROPION HCL SR 57 18 130 193
FINASTERIDE 55 43 133 150
EXFORGE 54 28 134 196
METFORMIN HCL ER 51 51 135 43
CEFDINIR 50 42 136 180
LANSOPRAZOLE 50 41 136 184
CELEBREX 50 38 136 89
HYDROXYCHLOROQUINE SULFATE 50 29 136 270
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 27, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.